{"id":95794,"date":"2016-06-07T17:30:55","date_gmt":"2016-06-07T21:30:55","guid":{"rendered":"\/news\/?p=95794"},"modified":"2016-06-07T16:37:43","modified_gmt":"2016-06-07T20:37:43","slug":"study-fad-used-faulty-data-when-approved-essure","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/","title":{"rendered":"Study: FDA used faulty data when it approved Essure"},"content":{"rendered":"
<\/div>

According to a new study out of Northwestern University, the US Food and Drug Administration has used faulty data<\/a> in its approval process for a variety of products over the past fifteen years, including the Essure sterilization device.<\/p>\n

\u201cOur results reveal significant weaknesses in the preapproval and post approval regulation of high-risk obstetrics and gynecology devices,” the authors said.<\/p>\n

As Live Action News has previously covered<\/a>, objections to Essure on safety grounds have come from both the pro-life and pro-choice camps. The device has been the subject of more than 5,000 complaints to the FDA, which has been accused<\/a> of downplaying its effects, which include both debilitating harm to women and deaths of babies conceived despite their mothers using the device.<\/p>\n

According to LifeSiteNews, the study’s\u00a0researchers noted<\/a>:<\/p>\n

 <\/p>\n

\n

Of the 18 ob-gyn devices reviewed for the study, six of them, or 33 percent, were not required to go through post-market studies to examine ongoing safety.<\/p>\n

Four of the devices, or 22 percent, were approved despite failing to demonstrate effectiveness in clinical trials.<\/p>\n

Three devices were ultimately withdrawn from the market after approval. Of those three, two had not been reviewed by the FDA\u2019s obstetrics and gynecology advisory committee\u2019s physician experts, and the one that was reviewed by the committee did not get its recommendation for approval.<\/p>\n<\/blockquote>\n

The FDA approved Essure in 2002, but according to the researchers it only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.<\/p>\n

“There are no explicit requirements about conducting randomized-controlled trials or post-market surveillance for medical devices,\u201d Dr. Steve Xu said, noting that such devices are subject to much looser scrutiny than drugs, with review requirements decided on a case-by-case basis.<\/p>\n","protected":false},"excerpt":{"rendered":"

According to a new study out of Northwestern University, the US Food and Drug Administration has used faulty data in its approval process for a variety of products over the past fifteen years, including the Essure sterilization device. \u201cOur results reveal significant weaknesses in the preapproval and post approval regulation of high-risk obstetrics and gynecology […]<\/p>\n","protected":false},"author":54,"featured_media":56140,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false},"categories":[3473],"tags":[145,24,4028,617,9049,1792,8564,3876,9048,1243,998],"yoast_head":"\nStudy: FDA used faulty data when it approved Essure<\/title>\n<meta name=\"description\" content=\"The FDA approved Essure in 2002, but only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Study: FDA used faulty data when it approved Essure\" \/>\n<meta property=\"og:description\" content=\"The FDA approved Essure in 2002, but only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Action News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/liveaction\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-07T21:30:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-06-07T20:37:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2014\/11\/essure.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"672\" \/>\n\t<meta property=\"og:image:height\" content=\"313\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Calvin Freiburger\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@liveaction\" \/>\n<meta name=\"twitter:site\" content=\"@liveaction\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Calvin Freiburger\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\"},\"author\":{\"name\":\"Calvin Freiburger\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/6eb2bf94c8064b71953ba137bf413c4d\"},\"headline\":\"Study: FDA used faulty data when it approved Essure\",\"datePublished\":\"2016-06-07T21:30:55+00:00\",\"dateModified\":\"2016-06-07T20:37:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\"},\"wordCount\":293,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"keywords\":[\"Birth Control\",\"contraception\",\"Essure\",\"FDA\",\"fetal deaths\",\"Food and Drug Administration\",\"Northwestern University\",\"safety standards\",\"side effects\",\"sterilization\",\"women's health\"],\"articleSection\":[\"Newsbreak\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\",\"name\":\"Study: FDA used faulty data when it approved Essure\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\"},\"datePublished\":\"2016-06-07T21:30:55+00:00\",\"dateModified\":\"2016-06-07T20:37:43+00:00\",\"description\":\"The FDA approved Essure in 2002, but only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.\",\"breadcrumb\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/archive.liveaction.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Study: FDA used faulty data when it approved Essure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"name\":\"Live Action News\",\"description\":\"Covering Human Rights, Abortion, & Pro-Life Issues\",\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\",\"name\":\"Live Action\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"contentUrl\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"width\":701,\"height\":710,\"caption\":\"Live Action\"},\"image\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/liveaction\",\"https:\/\/twitter.com\/liveaction\",\"https:\/\/www.instagram.com\/liveactionorg\/\",\"https:\/\/www.pinterest.com\/LiveActionFilms\/\",\"https:\/\/www.youtube.com\/user\/LiveActionFilms\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/6eb2bf94c8064b71953ba137bf413c4d\",\"name\":\"Calvin Freiburger\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7e27533b6967b0c47cce543ba67e2a7a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7e27533b6967b0c47cce543ba67e2a7a?s=96&d=mm&r=g\",\"caption\":\"Calvin Freiburger\"},\"description\":\"Calvin Freiburger is a Wisconsin-based conservative writer and 2011 Hillsdale College graduate, dedicated to the principles of the American Founding\u2014individual liberty, limited government, public virtue, free markets, and strong defense\u2014though he believes no issue is more important than defending the unalienable rights of society\u2019s most vulnerable members. Calvin is an editor and administrator for TheFederalistPapers.org, and his work has appeared on NewsRealBlog.com, PatriotUpdate.com, LifeNews.com, LifeSiteNews.com, RightWisconsin.com, AmericanThinker.com, Stream.org, AmericanClarion.org, and more. Please check out his official website, ConservativeStandards.com. Follow @CalFreiburger\",\"url\":\"https:\/\/archive.liveaction.org\/news\/author\/calvin-freiburger\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Study: FDA used faulty data when it approved Essure","description":"The FDA approved Essure in 2002, but only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/","og_locale":"en_US","og_type":"article","og_title":"Study: FDA used faulty data when it approved Essure","og_description":"The FDA approved Essure in 2002, but only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.","og_url":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/","og_site_name":"Live Action News","article_publisher":"https:\/\/www.facebook.com\/liveaction","article_published_time":"2016-06-07T21:30:55+00:00","article_modified_time":"2016-06-07T20:37:43+00:00","og_image":[{"width":672,"height":313,"url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2014\/11\/essure.jpg","type":"image\/jpeg"}],"author":"Calvin Freiburger","twitter_card":"summary_large_image","twitter_creator":"@liveaction","twitter_site":"@liveaction","twitter_misc":{"Written by":"Calvin Freiburger","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#article","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/"},"author":{"name":"Calvin Freiburger","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/6eb2bf94c8064b71953ba137bf413c4d"},"headline":"Study: FDA used faulty data when it approved Essure","datePublished":"2016-06-07T21:30:55+00:00","dateModified":"2016-06-07T20:37:43+00:00","mainEntityOfPage":{"@id":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/"},"wordCount":293,"commentCount":0,"publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"keywords":["Birth Control","contraception","Essure","FDA","fetal deaths","Food and Drug Administration","Northwestern University","safety standards","side effects","sterilization","women's health"],"articleSection":["Newsbreak"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/","url":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/","name":"Study: FDA used faulty data when it approved Essure","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/#website"},"datePublished":"2016-06-07T21:30:55+00:00","dateModified":"2016-06-07T20:37:43+00:00","description":"The FDA approved Essure in 2002, but only did so on evidence pertaining to short-term effects and without adequate follow-up once it was on the market.","breadcrumb":{"@id":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/archive.liveaction.org\/news\/study-fad-used-faulty-data-when-approved-essure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/archive.liveaction.org\/news\/"},{"@type":"ListItem","position":2,"name":"Study: FDA used faulty data when it approved Essure"}]},{"@type":"WebSite","@id":"https:\/\/archive.liveaction.org\/news\/#website","url":"https:\/\/archive.liveaction.org\/news\/","name":"Live Action News","description":"Covering Human Rights, Abortion, & Pro-Life Issues","publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/archive.liveaction.org\/news\/#organization","name":"Live Action","url":"https:\/\/archive.liveaction.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","contentUrl":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","width":701,"height":710,"caption":"Live Action"},"image":{"@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/liveaction","https:\/\/twitter.com\/liveaction","https:\/\/www.instagram.com\/liveactionorg\/","https:\/\/www.pinterest.com\/LiveActionFilms\/","https:\/\/www.youtube.com\/user\/LiveActionFilms"]},{"@type":"Person","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/6eb2bf94c8064b71953ba137bf413c4d","name":"Calvin Freiburger","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7e27533b6967b0c47cce543ba67e2a7a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7e27533b6967b0c47cce543ba67e2a7a?s=96&d=mm&r=g","caption":"Calvin Freiburger"},"description":"Calvin Freiburger is a Wisconsin-based conservative writer and 2011 Hillsdale College graduate, dedicated to the principles of the American Founding\u2014individual liberty, limited government, public virtue, free markets, and strong defense\u2014though he believes no issue is more important than defending the unalienable rights of society\u2019s most vulnerable members. Calvin is an editor and administrator for TheFederalistPapers.org, and his work has appeared on NewsRealBlog.com, PatriotUpdate.com, LifeNews.com, LifeSiteNews.com, RightWisconsin.com, AmericanThinker.com, Stream.org, AmericanClarion.org, and more. Please check out his official website, ConservativeStandards.com. Follow @CalFreiburger","url":"https:\/\/archive.liveaction.org\/news\/author\/calvin-freiburger\/"}]}},"_links":{"self":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/95794"}],"collection":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/users\/54"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/comments?post=95794"}],"version-history":[{"count":3,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/95794\/revisions"}],"predecessor-version":[{"id":95832,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/95794\/revisions\/95832"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media\/56140"}],"wp:attachment":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media?parent=95794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/categories?post=95794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/tags?post=95794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}